Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVP-6124 and donepezil in a scopolamine challenge crossover study in healthy elderly volunteers
NL-OMON37445Active, not recruiting
- Sponsor
- FORUM Pharmaceuticals
- Start
- Jan 2012
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of encenicline, donepezil and scopolamine in Alzheimer's disease (AD) and Dementia (3 arms), sponsored by FORUM Pharmaceuticals. Primary endpoints: Saccadic eye movements, Smooth pursuit eye movements and 15 more. Started Jan 2012; status: active, not recruiting.
02
Drugs
enceniclinedonepezilscopolamine
03
Conditions
Alzheimer's disease (AD)Dementia
Beyond the preview
Go deeper on NL-OMON37445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37445.